Eshelman Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 28

  • Portfolio
  • 10

  • Exits
  • 11

Exits

Eshelman Ventures General Information

Company Description

Founded in 2014, Eshelman Ventures is a venture capital firm based in Wilmington, North Carolina. The firm seeks to invest in companies operating in the healthcare sector.

Business Details

Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 319 North 3rd Street
  • Suite 301
  • Wilmington, NC 28401
  • United States
+1 (910) 000-0000

Eshelman Ventures Investments (28)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Sapience Therapeutics 31-May-2022 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
Incyclix Bio 31-Mar-2022 00000 00000 0000 Drug Discovery Clinical Trials - General
Incyclix Bio 05-Aug-2020 00000 00000 000 Drug Discovery Clinical Trials - General
Fountain Therapeutics 19-Feb-2020 00000 00000 000 Drug Discovery Generating Revenue
Kinnate Biopharma 12-Dec-2019 00000 00000 000.00 Drug Discovery Generating Revenue
Aruna Bio 24-Jul-2019 00000 00000 000.00 Drug Delivery Pre-Clinical Trials
Asepticys 28-Nov-2018 00000 00000 00.000 Drug Discovery Out of Business 0000000 00000000
Kinnate Biopharma 01-Apr-2018 00000 00000 0000 Drug Discovery Generating Revenue
Liquidia Technologies 20-Feb-2018 Later Stage VC 000.00 Drug Discovery Generating Revenue/Not Profitable
AeroMD 01-Jan-2018 Early Stage VC Other Healthcare Services Generating Revenue
You’re viewing 10 of 28 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eshelman Ventures Exits (11)

Company Name Exit Date Exit Type Exit Size
Meryx 07-Dec-2021 Merger/Acquisition
Asepticys 18-Mar-2021 000 00 00000000
Kinnate Biopharma 03-Dec-2020 000 00000
Innocrin Pharmaceuticals 01-Oct-2019 000 00 00000000
Liquidia Technologies 26-Jul-2018 000 0000
Eyenovia 25-Jan-2018 000 000.00
Support Group International 01-Jan-2018 000000000 00000000
Neoantigenics 01-Sep-2017 000 00 00000000
G1 Therapeutics 17-May-2017 IPO 00000
The Medicines Company 01-Feb-2016 Merger/Acquisition 00000
You’re viewing 10 of 11 exits. Get the full list »

Eshelman Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Eshelman Ventures Management, Team & Partners (1)

Name Title Deals Funds Boards Office
Fredric Eshelman Founder & Principal 0 0 Wilmington, NC
To view Eshelman Ventures’s complete team members history, request access »

Eshelman Ventures Co-Investors (6)

Name With Exits Lead Partner Series Industry
Bristol-Myers Squibb 1 Series chart Industry bar
Khosla Ventures 0 Series chart Industry bar
Kingdon Capital Management 0 Series chart Industry bar
NexPoint 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
You’re viewing 5 of 6 co-investors. Get the full list »

Eshelman Ventures FAQs

  • What is Eshelman Ventures?

    Founded in 2014, Eshelman Ventures is a venture capital firm based in Wilmington, North Carolina.

  • When was Eshelman Ventures founded?

    Eshelman Ventures was founded in 2014.

  • Who is the founder of Eshelman Ventures?

    Fredric Eshelman is the founder of Eshelman Ventures.

  • Where is Eshelman Ventures headquartered?

    Eshelman Ventures is headquartered in Wilmington, NC.

  • How many investments has Eshelman Ventures made?

    Eshelman Ventures has made 28 investments.

  • What has Eshelman Ventures invested in?

    Eshelman Ventures has made numerous investments in companies like Sapience Therapeutics, Incyclix Bio, and Fountain Therapeutics within the Drug Discovery industry.

  • What has Eshelman Ventures invested in recently?

    Eshelman Ventures's latest investment was on 31-May-2022 in Sapience Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »